Patents by Inventor Mark C. Brister

Mark C. Brister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10722152
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: July 28, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Patent number: 10709592
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: July 14, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson
  • Patent number: 10709362
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: July 14, 2020
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Patent number: 10709363
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: July 14, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Patent number: 10709332
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: July 14, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower
  • Publication number: 20200196924
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 25, 2020
    Inventor: Mark C. Brister
  • Publication number: 20200187778
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower
  • Publication number: 20200187776
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Application
    Filed: February 20, 2020
    Publication date: June 18, 2020
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Publication number: 20200178863
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventor: Mark C. Brister
  • Publication number: 20200179147
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20200178862
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventor: Mark C. Brister
  • Publication number: 20200178861
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Inventor: Mark C. Brister
  • Patent number: 10675165
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: June 9, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Patent number: 10660778
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. More particularly, apparatuses and methods for enabling volume-occupying intragastric devices to pass through the digestive system are provided.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: May 26, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Eleanor McCarthy, Mark C. Brister, Antonio C. Llevares, Betty Wong
  • Patent number: 10624539
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 21, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower
  • Patent number: 10617545
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: April 14, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Sheldon Nelson, Daniel J. Proctor, Andrew P. Rasdal, Keoni John Sundseth, Amy D. L. VandenBerg, Betty Wong
  • Patent number: 10610102
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 7, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower
  • Patent number: 10610396
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: April 7, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 10610103
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: April 7, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, Jr., James Patrick Thrower
  • Publication number: 20200100714
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: November 21, 2019
    Publication date: April 2, 2020
    Inventors: Peter C. Simpson, Mark C. Brister, Matthew D. Wightlin